Showing results (2431-2440 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|September 8, 2000
Expert judgement in pharmacoeconomic studies. Guidance and future useC Evans, B Crawford
Pharmacoeconomics|May 27, 1999
A review of the economics of the prevention and control of rabies. Part 1: Global impact and rabies in humansM I Meltzer, C E Rupprecht
Pharmacoeconomics|September 4, 1997
The costs of epilepsy and cost-based evaluations of anticonvulsantsW G Johnson
Pharmacoeconomics|October 4, 1997
Measuring sensitivity in pharmacoeconomic studies. An integration of point-sensitivity and range-sensitivityM J Nuijten, M Hardens
Pharmacoeconomics|August 28, 2016
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology AppraisalBram L T Ramaekers, Rob Riemsma, Florian Tomini, et al.
Pharmacoeconomics|August 19, 2021
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UKLiz Morrell, James Buchanan, Sian Rees, et al.
Pharmacoeconomics|July 5, 2016
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A TutorialStéphane Verguet, Jane J Kim, Dean T Jamison
Pharmacoeconomics|January 9, 1992
Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart diseaseP Chrisp, N J Lewis, R J Milne
Pharmacoeconomics|June 3, 1999
Valuing health-related quality of life. Issues and controversiesP Dolan
Pharmacoeconomics|June 16, 2026
Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice ExperimentRakhee Raghunandan, Parisa Aslani, Timothy F Chen, et al.
Pageof 336